Skip to content

Clinical trials

Phase 1/2 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 1/2 Country / region: Brazil Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20211
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting2
Active, not recruiting1
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen1
Instituto Nacional de Cancer, Brazil1
Therapeutic Advances in Childhood Leukemia Consortium1
University of Sao Paulo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Lymphoma, Non-Hodgkin2
Recurrence2
Graft vs Host Disease1
Hodgkin Disease1
Leukemia, Myeloid, Acute1
Lymphoma1
Myelodysplastic Syndromes1
Neoplasm, Residual1

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.